IFAM
KYNB

Institutional & Family Asset Management’s Kyntra Bio KYNB Stock Holding History

Institutional & Family Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed -$448 – 767
2023
Q1 		$448 Hold
1
– – ﹤0.01% 679
2022
Q4 		$384 Buy
+1
New +$383 ﹤0.01% 680
2019
Q2 		– Sell
-1
Closed -$2K – 846
2019
Q1 		$2K Hold
1
– – ﹤0.01% 710
2018
Q4 		$1K Hold
1
– – ﹤0.01% 762
2018
Q3 		$2K Hold
1
– – ﹤0.01% 735
2018
Q2 		$2K Hold
1
– – ﹤0.01% 720
2018
Q1 		$1K Buy
+1
New +$1.32K ﹤0.01% 781

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Institutional & Family Asset Management's KYNB Position: Q2 2023 in Review

Institutional & Family Asset Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 1 share — an estimated $448 sold.

Institutional & Family Asset Management first reported a position in KYNB in Q1 2018 and held it in 7 quarters. The position peaked at $2K in Q1 2019. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Institutional & Family Asset Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Institutional & Family Asset Management sold 1 Kyntra Bio share in Q2 2023, an estimated $448.
  • Institutional & Family Asset Management first reported a position in Kyntra Bio in Q1 2018 and held it in 7 quarters.
  • Institutional & Family Asset Management's Kyntra Bio position peaked at $2K in Q1 2019.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Institutional & Family Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.